AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2013

Nov 12, 2013

32870_dirs_2013-11-12_3fb8b089-7ba8-4b3a-acac-f8d4a277fbb2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2013-11-07

Reporting Person: Abdun-Nabi Daniel (Director, CEO & President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-11-07	Common Stock	M	4613	$10.13	Acquired	100624	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-11-07	Employee Stock Option (right to buy)	$10.13	M	4613	Disposed	2013-12-12	Common Stock (4613)	Direct

Footnotes

F1: The reporting person engaged in an exercise and hold transaction with respect to these stock options, which would otherwise expire on December 12, 2013.

F2: These stock options are fully vested.